Anthropic OpenAI: Which Giant Could Deliver Bigger Returns?
Two AI pioneers sit on the public markets' doorstep with wall-high expectations. This guide breaks down which giant—a...
We evaluate which retirement option—index fund or target date fund—fits your timeline, risk profile, and tax strategy for a smoother retirement.
26,044 articlesTwo AI pioneers sit on the public markets' doorstep with wall-high expectations. This guide breaks down which giant—a...
A leading investment fund recently opened a sizable stake in STGW after marquee client wins. Here’s what this move co...
When a major investor dumped million from a high-yield closed-end fund, it sent a clear message about risk, liquidity...
A recent SEC filing details Helix Partners exiting its Cinemark stake. This article breaks down what that exit means ...
A major hedge fund just placed a multi-million bet on a biotech company after FDA approval. This article breaks down ...
A hedge fund made a sizable Ultragenyx purchase as the stock slipped about 30% over the prior year. This article brea...
Two beloved names in consumer e-commerce clash in 2026. This guide breaks down which stock—Etsy or Wayfair—offers sma...
A major fund recently disclosed a sizable stake in Boston Properties, sparking questions about what this move signals...
A major wealth manager just unveiled a multi-million-dollar stake in a commodity-focused ETF boosting income appeal. ...
A major move by hedge fund incline global to liquidate its Maplebear stake prompts a closer look at CART stock. Read ...
Two biotech powerhouses take very different routes: Moderna builds medicines with mRNA, while Recursion uses machine ...
Solana leads in current on-chain activity as of mid-May 2026, with XRP showing growing throughput and Cardano lagging...